Recent Structural Insights into Cytochrome P450 Function.
暂无分享,去创建一个
[1] M. Waterman,et al. Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections*♦ , 2009, The Journal of Biological Chemistry.
[2] Young-Tae Lee,et al. P450cam visits an open conformation in the absence of substrate. , 2010, Biochemistry.
[3] T. Poulos,et al. Structure of cytochrome P450eryF involved in erythromycin biosynthesis , 1995, Nature Structural Biology.
[4] F. Guengerich,et al. Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. , 1995, Chemical research in toxicology.
[5] T. Poulos,et al. The crystal structure of chloroperoxidase: a heme peroxidase--cytochrome P450 functional hybrid. , 1995, Structure.
[6] Jeffrey B. Endelman,et al. Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450 , 2006, PLoS biology.
[7] T. Poulos,et al. Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I Ligand* , 2011, The Journal of Biological Chemistry.
[8] M. J. Coon,et al. Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes. , 1968, The Journal of biological chemistry.
[9] Shunji Takahashi,et al. Structure-Function Analyses of Cytochrome P450revI Involved in Reveromycin A Biosynthesis and Evaluation of the Biological Activity of Its Substrate, Reveromycin T* , 2014, The Journal of Biological Chemistry.
[10] T. Poulos,et al. Structural Basis for Effector Control and Redox Partner Recognition in Cytochrome P450 , 2013, Science.
[11] T. Poulos,et al. Anion-Dependent Stimulation of CYP3A4 Monooxygenase. , 2015, Biochemistry.
[12] Eric F. Johnson,et al. Structural Diversity of Eukaryotic Membrane Cytochrome P450s* , 2013, The Journal of Biological Chemistry.
[13] Jessica Lo,et al. Novel aromatase inhibitors by structure-guided design. , 2012, Journal of medicinal chemistry.
[14] M. Waterman,et al. Role of Active Site Water Molecules and Substrate Hydroxyl Groups in Oxygen Activation by Cytochrome P450 158A2 , 2005, Journal of Biological Chemistry.
[15] F. Guengerich,et al. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.
[16] J. Pandit,et al. Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors , 2015, Journal of medicinal chemistry.
[17] Kenneth A. Johnson,et al. Role of Induced Fit in Enzyme Specificity: A Molecular Forward/Reverse Switch* , 2008, Journal of Biological Chemistry.
[18] Frank E. Blaney,et al. Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.
[19] K. J. Ryan. Conversion of androstenedione to estrone by placental microsomes. , 1958, Biochimica et biophysica acta.
[20] Eric F. Johnson,et al. Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1* , 2010, The Journal of Biological Chemistry.
[21] F. Guengerich,et al. Conversion of 7-Dehydrocholesterol to 7-Ketocholesterol Is Catalyzed by Human Cytochrome P450 7A1 and Occurs by Direct Oxidation without an Epoxide Intermediate , 2011, The Journal of Biological Chemistry.
[22] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[23] Bradley S Moore,et al. Binding of Two Flaviolin Substrate Molecules, Oxidative Coupling, and Crystal Structure of Streptomyces coelicolor A3(2) Cytochrome P450 158A2* , 2005, Journal of Biological Chemistry.
[24] Cataloging the Repertoire of Nature's Blowtorch, P450. , 2009, Chemistry & biology.
[25] M. Waterman,et al. The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. , 1995, Archives of biochemistry and biophysics.
[26] T. Poulos,et al. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] L. Kang,et al. Functional characterization of CYP107W1 from Streptomyces avermitilis and biosynthesis of macrolide oligomycin A. , 2015, Archives of biochemistry and biophysics.
[28] Kang Lan Tee,et al. Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum , 2015, Proceedings of the National Academy of Sciences.
[29] W. Miller,et al. Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.
[30] T. Omura,et al. A new cytochrome in liver microsomes. , 1962, The Journal of biological chemistry.
[31] The crystal structure of chloroperoxidase: a heme peroxidase--cytochrome P450 functional hybrid. , 1995, Structure.
[32] D. Lamb,et al. Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs* , 2015, The Journal of Biological Chemistry.
[33] J. Groves. Models and Mechanisms of Cytochrome P450 Action , 2005 .
[34] F. Mackenzie,et al. Structural characterization of human cholesterol 7α-hydroxylase , 2014, Journal of Lipid Research.
[35] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[36] S A van Acker,et al. A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.
[37] F. Guengerich,et al. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. , 1985, Cancer research.
[38] Hee-won Park,et al. Structural basis of human CYP51 inhibition by antifungal azoles. , 2010, Journal of molecular biology.
[39] Eric F. Johnson,et al. The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.
[40] J. Tainer,et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. , 1998, Science.
[41] Jessica Lo,et al. Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase. , 2013, Biochemistry.
[42] A. D. Rodrigues,et al. Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir , 1997, Antimicrobial agents and chemotherapy.
[43] K. Korzekwa,et al. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. , 1994, Biochemistry.
[44] D. Koshland,et al. Comparison of experimental binding data and theoretical models in proteins containing subunits. , 1966, Biochemistry.
[45] Slobodan Rendic,et al. Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals , 2014, Chemical research in toxicology.
[46] C David Stout,et al. Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.
[47] Takashi Hayashi,et al. Enzyme-substrate complex structures of CYP154C5 shed light on its mode of highly selective steroid hydroxylation. , 2014, Acta crystallographica. Section D, Biological crystallography.
[48] Jose Cosme,et al. Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.
[49] F. Guengerich. Characterization of human cytochrome P450 enzymes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] H. Sugimoto,et al. Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. , 2011, The Journal of biological chemistry.
[51] M. Waterman,et al. Structural and Kinetic Basis of Steroid 17 , 20-Lyase Activity in Teleost Fish Cytochrome P 450 17 A 1 and Its Absence in Cytochrome P 450 17 A 2 * , 2015 .
[52] B. Brodie,et al. The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. , 1957, The Journal of pharmacology and experimental therapeutics.
[53] Bahman Zohuri. Thermodynamics of Cycles , 2017 .
[54] F. Guengerich,et al. Human cytochrome P-450 enzymes. , 1992, Life sciences.
[55] T. Poulos,et al. Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] Eric F. Johnson,et al. Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.
[57] Jose Cosme,et al. Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.
[58] T. Poulos,et al. Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. , 2013, Biochemistry.
[59] T. Poulos,et al. Structures of Cytochrome P450 Enzymes , 2015 .
[60] T. Poulos,et al. Preliminary crystallographic data on cytochrome P-450CAM. , 1982, The Journal of biological chemistry.
[61] J. Idle,et al. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.
[62] Michael J. E. Sternberg,et al. Evidence That Aspartic Acid 301 Is a Critical Substrate-Contact Residue in the Active Site of Cytochrome P450 2D6 (*) , 1995, The Journal of Biological Chemistry.
[63] T. Yuen,et al. Structure–phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia , 2013, Proceedings of the National Academy of Sciences.
[64] J Deisenhofer,et al. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.
[65] J. Laurence,et al. Human Cytochrome P450 17A1 Conformational Selection , 2014, The Journal of Biological Chemistry.
[66] B. Griffin,et al. Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. , 1972, Biochemistry.
[67] J. Miller,et al. The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. , 1948, The Journal of biological chemistry.
[68] E. Scott,et al. CYTOCHROME P450 17A1 STRUCTURES WITH PROSTATE CANCER DRUGS ABIRATERONE AND TOK-001 , 2011, Nature.
[69] K. Battaile,et al. Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode* , 2010, The Journal of Biological Chemistry.
[70] D. Ghosh,et al. Evidence for an Elevated Aspartate pKa in the Active Site of Human Aromatase* , 2014, The Journal of Biological Chemistry.
[71] W. Pangborn,et al. Structural basis for androgen specificity and oestrogen synthesis in human aromatase , 2009, Nature.
[72] M. Waterman,et al. Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase , 2015, The Journal of Biological Chemistry.
[73] M. Huang,et al. Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids. , 1981, The Journal of biological chemistry.
[74] G. Szklarz,et al. Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism* , 2013, The Journal of Biological Chemistry.
[75] David L. Williams,et al. Correction: The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development , 2016, PLoS neglected tropical diseases.
[76] F. Guengerich,et al. Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.
[77] Andrew W. Munro,et al. Structure and Biochemical Properties of the Alkene Producing Cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp. 8456 Bacterium* , 2014, The Journal of Biological Chemistry.
[78] Eric F. Johnson,et al. Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding* , 2015, The Journal of Biological Chemistry.
[79] S. Imaoka,et al. Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. , 1992, Biochemistry.
[80] Job L Grant,et al. Decarboxylation of fatty acids to terminal alkenes by cytochrome P450 compound I. , 2015, Journal of the American Chemical Society.
[81] J. Laurence,et al. Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR* , 2015, The Journal of Biological Chemistry.
[82] B C Finzel,et al. The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. , 1985, The Journal of biological chemistry.
[83] J. Peterson. Camphor binding by Pseudomonas putida cytochrome P-450 , 1971 .
[84] B C Finzel,et al. Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. , 1986, Biochemistry.
[85] M. Cryle,et al. Structure of OxyAtei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade , 2016, FEBS letters.
[86] L. Kang,et al. Structural Analysis of the Streptomyces avermitilis CYP107W1-Oligomycin A Complex and Role of the Tryptophan 178 Residue , 2016, Molecules and cells.
[87] Eric F. Johnson,et al. The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.
[88] F Peter Guengerich,et al. Three-dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-associated Variants* , 2012, The Journal of Biological Chemistry.
[89] F. Mackenzie,et al. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system , 2011, Proceedings of the National Academy of Sciences.
[90] E. Scott,et al. Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates* , 2014, The Journal of Biological Chemistry.
[91] H. Barnes,et al. Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[92] A. Bonvin,et al. The HADDOCK web server for data-driven biomolecular docking , 2010, Nature Protocols.
[93] S. Kandel,et al. Analysis of Cytochrome P450 CYP119 Ligand-dependent Conformational Dynamics by Two-dimensional NMR and X-ray Crystallography* , 2015, The Journal of Biological Chemistry.
[94] I. C. Gunsalus,et al. A soluble cytochrome P-450 functional in methylene hydroxylation. , 1968, The Journal of biological chemistry.
[95] J. Laurence,et al. Substrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR* , 2013, The Journal of Biological Chemistry.
[96] F. Guengerich,et al. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. , 1993, Archives of biochemistry and biophysics.
[97] F. Guengerich,et al. Kinetic Analysis of Oxidation of Coumarins by Human Cytochrome P450 2A6* , 2005, Journal of Biological Chemistry.
[98] T. Poulos,et al. Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism. , 2014, Current topics in medicinal chemistry.
[99] F Peter Guengerich,et al. Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.
[100] E. Scott,et al. Structures of Human Cytochrome P-450 2E1 , 2008, Journal of Biological Chemistry.
[101] Eric F. Johnson,et al. Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound* , 2012, The Journal of Biological Chemistry.
[102] T. Pochapsky,et al. Detection of substrate-dependent conformational changes in the P450 fold by nuclear magnetic resonance , 2016, Scientific Reports.
[103] F. Guengerich,et al. Unusual Cytochrome P450 Enzymes and Reactions* , 2013, The Journal of Biological Chemistry.
[104] W. Miller,et al. P450 enzymes in steroid processing , 2015 .
[105] J. Madura,et al. Solution structural ensembles of substrate-free cytochrome P450(cam). , 2012, Biochemistry.
[106] M. Waterman,et al. Structural Basis for Rational Design of Inhibitors Targeting Trypanosoma cruzi Sterol 14α-Demethylase: Two Regions of the Enzyme Molecule Potentiate Its Inhibition , 2014, Journal of medicinal chemistry.
[107] S. Guan,et al. Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest‐4‐en‐3‐one , 2010, Molecular microbiology.
[108] M. Egli,et al. Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia. , 2015, Molecular endocrinology.
[109] P. R. Montellano. Substrate Oxidation by Cytochrome P450 Enzymes , 2015 .
[110] M. Waterman,et al. Structural and Kinetic Basis of Steroid 17α,20-Lyase Activity in Teleost Fish Cytochrome P450 17A1 and Its Absence in Cytochrome P450 17A2* , 2014, The Journal of Biological Chemistry.
[111] Kenneth A. Johnson,et al. Role of induced fit in limiting discrimination against AZT by HIV reverse transcriptase. , 2011, Biochemistry.
[112] Dong-Sun Lee,et al. Substrate Recognition and Molecular Mechanism of Fatty Acid Hydroxylation by Cytochrome P450 from Bacillus subtilis , 2003, The Journal of Biological Chemistry.
[113] Gordon C K Roberts,et al. Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6* , 2003, The Journal of Biological Chemistry.
[114] Robert L. Smith. The Paton Prize Award. The discovery of the debrisoquine hydroxylation polymorphism: scientific and clinical impact and consequences. , 2001, Toxicology.
[115] T. Shimada,et al. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[116] P. Ortiz de Montellano,et al. Cholesterol Ester Oxidation by Mycobacterial Cytochrome P450* , 2014, The Journal of Biological Chemistry.
[117] M. Nishiyama,et al. Structure of the quinoline N‐hydroxylating cytochrome P450 RauA, an essential enzyme that confers antibiotic activity on aurachin alkaloids , 2014, FEBS letters.
[118] T. Sjögren,et al. Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.
[119] R. Auchus,et al. Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5* , 2014, The Journal of Biological Chemistry.
[120] L. Waskell,et al. Kinetic and Structural Characterization of the Interaction between the FMN Binding Domain of Cytochrome P450 Reductase and Cytochrome c* , 2014, The Journal of Biological Chemistry.
[121] D E McRee,et al. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.
[122] Serge Léger,et al. Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. , 2002, Biochemistry.